Home/Filings/4/0001179110-04-001677
4//SEC Filing

HSIA DAVID C 4

Accession 0001179110-04-001677

CIK 0000884629other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 5:05 PM ET

Size

6.1 KB

Accession

0001179110-04-001677

Insider Transaction Report

Form 4
Period: 2004-01-22
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
  • Sale

    Common Stock, par value $0.0033

    2004-01-22$48.71/sh1,250$60,892587,814 total(indirect: By Trust)
Holdings
  • Common Stock, par value $0.0033

    (indirect: By Trust)
    40,000
  • Common Stock, par value $0.0033

    60,000
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans dated August 27, 2003.

Issuer

WATSON PHARMACEUTICALS INC

CIK 0000884629

Entity typeother

Related Parties

1
  • filerCIK 0001258176

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:05 PM ET
Size
6.1 KB